- Home
- GPRK vs HRTX Comparison
GPRK vs HRTX Comparison
Compare GPRK & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- HRTX
- Stock Information
- Founded
- GPRK 2002
- HRTX 1983
- Country
- GPRK Colombia
- HRTX United States
- Employees
- GPRK 476
- HRTX N/A
- Industry
- GPRK Oil & Gas Production
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- HRTX Health Care
- Exchange
- GPRK Nasdaq
- HRTX Nasdaq
- Market Cap
- GPRK 351.5M
- HRTX 325.0M
- IPO Year
- GPRK N/A
- HRTX 1987
- Fundamental
- Price
- GPRK $7.06
- HRTX $2.15
- Analyst Decision
- GPRK Buy
- HRTX Strong Buy
- Analyst Count
- GPRK 1
- HRTX 2
- Target Price
- GPRK $11.00
- HRTX $5.00
- AVG Volume (30 Days)
- GPRK 651.0K
- HRTX 1.5M
- Earning Date
- GPRK 08-13-2025
- HRTX 08-05-2025
- Dividend Yield
- GPRK 8.33%
- HRTX N/A
- EPS Growth
- GPRK N/A
- HRTX N/A
- EPS
- GPRK 1.51
- HRTX N/A
- Revenue
- GPRK $630,771,000.00
- HRTX $148,518,000.00
- Revenue This Year
- GPRK N/A
- HRTX $12.08
- Revenue Next Year
- GPRK $5.80
- HRTX $12.57
- P/E Ratio
- GPRK $4.37
- HRTX N/A
- Revenue Growth
- GPRK N/A
- HRTX 12.43
- 52 Week Low
- GPRK $5.66
- HRTX $1.04
- 52 Week High
- GPRK $11.72
- HRTX $3.73
- Technical
- Relative Strength Index (RSI)
- GPRK 51.70
- HRTX 56.07
- Support Level
- GPRK $6.45
- HRTX $2.04
- Resistance Level
- GPRK $6.88
- HRTX $2.23
- Average True Range (ATR)
- GPRK 0.31
- HRTX 0.13
- MACD
- GPRK -0.07
- HRTX 0.01
- Stochastic Oscillator
- GPRK 43.26
- HRTX 62.50
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.